Monthly Prescribing Reference5d
STEP UP Trial: Significant Weight Loss Observed With Higher Dose Semaglutide
The phase 3 STEP UP trial enrolled 1407 adults aged 18 years and older with a body mass index of at least 30kg/m2 and without diabetes.
Hosted on MSN1d
Raquel Rodriguez: New Titles Mean More Opportunities For Women To Step Up
WWE introduced two brand new championships for the women’s division, the Women’s United States and Intercontinental titles.
Novo Nordisk’s Semaglutide 7.2mg s.c. achieved 21% weight loss in STEP UP trial
Novo Nordisk (NVO) announced headline results from STEP UP, a phase 3b trial in the global STEP programme. STEP UP is a ...
devdiscourse9d
Step It Up: Walking Towards Mental Well-being
With over 330 million affected globally, depression severely impacts quality of life. Physical inactivity exacerbates this ...
Novo Nordisk: STEP UP Trial Achieves Primary Endpoint - Quick Facts
Novo Nordisk (NVO) reported headline results from STEP UP, a phase 3b trial in the global STEP programme. The trial achieved primary ...